Abstract Background Group B Streptococcus (GBS) infection is one of the major causes of
neonatal morbidity and mortality. Universal GBS screening with intrapartum antibiotic …

Abstract Group B Streptococcus (GBS) is one of the most important pathogens for neonates.
This study included 69 invasive GBS diseases in neonates, including 7 early-onset disease …

Background: As no population-based studies of group B Streptococcus (GBS) colonization
rates in late pregnancy (at 35–37 weeks of gestation) have been conducted in China, the …

Introduction It is estimated that about 11–35% of pregnant women are colonized with Group
B streptococcus. Intrapartum antibiotic prophylaxis (IAP) is the primary intervention to …

Group B Streptococcus (GBS) is a leading cause of neonatal sepsis and an important cause
of maternal disease in many countries; however, no accurate population-based …

Objective To determine rates and results of maternal Group B streptococcus (GBS)
screening during pregnancy and identify sociodemographic characteristics associated with …

Background: Group B Streptococcus (GBS or S. agalactiae) is a major cause of severe
disease in neonates. In perinatal infections or early-onset disease, GBS is transmitted …

Background We examined the risk for Group B streptococcus (GBS)-related diseases in
newborns born to mothers who participated in a universal GBS screening program and to …

Abstract Background: Group B streptococcus (GBS) is an important cause of neonatal
sepsis. Guidelines advise to collect cultures at 35–37 weeks' gestation and to administer …

Aim In this study, we collected group B streptococcus (GBS) screening data and analyzed
screening rate, antimicrobial resistance rate, and neonatal observation room (NOR) …